Standardizing follow-up care through dedicated post-ACS clinics can improve the underutilization of lipid-lowering therapies and achievement of guideline-recommended LDL targets.
Standardizing follow-up care through dedicated post-ACS clinics represents a key opportunity to improve adherence to dyslipidemia guidelines and reduce residual cardiovascular risk.
Following an acute coronary syndrome (ACS), patients remain at a residual increased risk of adverse cardiovascular events. As such, secondary prevention strategies, including dyslipidemia management, are key in the delivery of post-ACS care. Multiple randomized controlled trials have highlighted the benefit of lipid-lowering therapies in reducing low-density lipoprotein cholesterol levels, an independent predictor of adverse cardiovascular events post-ACS. However, registries have demonstrated that post-ACS, a significant proportion of patients are not achieving guideline-recommended low-density lipoprotein target levels, and intensification of lipid-lowering therapies continues to be underutilized. This review assesses strategies in which post-ACS lipid management can be improved, in particular by standardizing follow-up care through dedicated post-ACS clinics.
Labinaz et al. (Mon,) conducted a review in Acute Coronary Syndrome. Lipid-lowering therapies was evaluated. Standardizing follow-up care through dedicated post-ACS clinics can improve the underutilization of lipid-lowering therapies and achievement of guideline-recommended LDL targets.